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Risk factors for myocardial 
infarction and stroke in Africa
develops silently over many years and is usually advanced by the 
time it becomes symptomatic. IHD and stroke are the main 
components of CVD and share common risk factors. The pro-
gression of atherosclerosis is accelerated by the presence of 
modifiable risk factors such as tobacco use, obesity, hypertension, 
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IntroductIon                                                               
Cardiovascular disease (CVD) accounted for 30% of all deaths 
worldwide according to estimates in 2005 and almost half of 
these deaths were in people under the age of 70 years.(1) According 
to the World Health Organisation (WHO), in 2005, more than 
1.1 million deaths in the African region were caused by cardiovas-
cular diseases and more than half of these were due to ischaemic 
heart disease (IHD) and stroke.(2) Projections suggest that this figure 
will almost double by 2030(3,2) and that IHD and stroke will become 
two of the three leading causes of death in low- and middle-income 
countries.(4) 
In African regions IHD is the leading cause of death in men and 
second leading cause of death in women over the age of 60 
years.(3) In South Africa approximately 33 and 60 people die per 
day because of a myocardial infarction or a stroke respectively.(5) 
The underlying pathology for CVD is atherosclerosis, which 
background: definitive information on the strength of asso-
ciation between various risk factors and cardiovascular 
disease in Africa is lacking. 
objective: We conducted a systematic review of studies 
investigating risk factors for acute myocardial infarction 
(AMI) and stroke in Africa. 
data sources: We searched Medline and Embase as well as 
the reference lists of the included articles.
study eligibility criteria: We included case-control and co-
hort studies conducted in an African country, which assessed 
risk factors for first episodes of (AMI) or stroke in people of 
any age. 
Methods: two independent reviewers screened studies for 
eligibility, extracted data and assessed study quality. We 
described measures of association (odds ratios) with con-
fidence intervals of risk factors for AMI and stroke separately. 
results: twelve articles reporting results from five case-
control studies met our inclusion criteria but only one study 
(IntErHEArt) investigated risk factors for AMI. no eli-
gible cohort studies were identified. the direction of as-
sociation for established risk factors for AMI and stroke seem 
to be similar globally but the strength of association of 
various risk factors varies between countries and within 
African ethnic groups. In Africa, diabetes and hypertension 
had the highest risk associated with AMI and hypertension 
was the strongest risk factor for stroke. overall, the quality of 
the included case-control studies was good.
conclusions and implications: our results confirm the urgent 
need for prospective studies investigating risk factors for 
AMI and stroke in African populations. A few high quality 
case-control studies exist but these do not adequately 
represent the cultural and genetic diversity in Africa, or the 
influence of infections on cardiovascular outcomes. dynamic 
risk factors that rely on self-report such as diet, physical 
activity and stress will be better assessed through longitudinal 




















diabetes and dyslipidemia.(6,7) Addressing risk factors through 
primary and secondary prevention strategies have been shown to 
reduce mortality and morbidity.(7)
Major risk factors for CVD in Africa may be similar to those in the 
Western world, but because African populations are of wide 
genetic and ethnic diversity, are heavily burdened by infectious 
diseases and at different stages of epidemiological health transi- 
tion, it is uncertain whether information from studies in economi-
cally more developed countries can be applied to the African 
context.(3,8,9) Definitive information on the strength of association 
between various risk factors and CVD in Africa is lacking,(3,8) pri-
marily due to insufficient research on non-communicable diseases, 
weak study designs and small sample sizes. In order to improve our 
understanding of the risk factors most relevant to African popu-
lations, to help inform targeted health promotion and primary 
prevention strategies, and to guide the design of future research 
we conducted a systematic review of high level epidemiological 
studies investigating risk factors for myocardial infarction and stroke 
conducted in Africa. 
MAtErIAls And MEtHods                                            
study eligibility
We included case-control or cohort studies conducted in African 
countries that assessed the association of specific risk factors 
(e.g. socio-demographic, family history, lifestyle, clinical, biochemi-
cal or other) for first episodes of acute myocardial infarction (AMI) 
or stroke. We considered only studies published in English but 
documented all potentially eligible studies reported in other 
languages. There was no restriction in terms of the setting in which 
studies were conducted or age of the participants. We excluded 
studies that reported on recurrent events or that did not specifi-
cally state that only first episode events were investigated. Studies 
that focused exclusively on women during pregnancy or the 
puerperium, or on patients with specific underlying cardiac 
abnormalities such as atrial fibrillation, cardiomyopathies or valvular 
heart disease were also excluded.
search strategy
A broad search strategy was developed with assistance from an 
experienced information specialist for electronic searches in 
Medline (1966 to 31 August 2010) and Embase (1972 to 10 
September 2010). We used exploded medical subject headings 
(MeSH) including Cerebrovascular Disorders, Myocardial Ischaemia, 
Stroke, Myocardial Infarction, and Africa; subject headings for Risk, 
Cohort or Case-Control, Prospective or Retrospective Studies in 
combination with text words including Heart Attack, Cerebro-
vascular Accident, Cerebrovascular Incident; as well as text words 
for all the African countries individually. The search terms for 
Africa were adapted from the search strategy developed by 
Siegfried et al.(10) The searches had no language restriction but 
were limited to humans. The specific search strategies can be 
found in Appendix 1. We searched the reference lists of articles 
included in this review for additional relevant studies.
The titles and/or abstracts of all articles identified were screened 
for eligibility by two independent reviewers (CL and LL) using pre-
specified criteria. Any abstract deemed by one of the reviewers as 
being potentially relevant was reviewed in full text. Any uncertainty 
or disagreement about eligibility was resolved through discussion 
and remaining uncertainty was resolved through discussion with a 
third reviewer (JV).
Data extraction
CL and LL independently extracted data from the eligible studies 
using a structured data extraction form with disagreements re-
solved through consensus and, where necessary, by consultation 
with JV. 
We planned to extract the following data: 
 ■ Study design (prospective or retrospective cohort study, nested 
or other case control study), sample selection and sample size, 
setting, eligibility criteria, and follow-up or data-collection 
period.
 ■ Information on pre-specified risk factors (along with potential 
confounders) as well as the definitions and methods used in 
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each study. These could include but were not limited to: socio-
demographic information (age, gender, ethnicity, employment, 
education and socio-economic status), family history, lifestyle 
factors (former or current tobacco use, physical activity, and 
dietary patterns and alcohol use), personal clinical history 
(hypertension, diabetes, dyslipidemia, depressive mood or 
psychological stress), waist circumference (WC) or body mass 
index (BMI), HIV status and use of ARV treatment and 
biochemical markers (C-reactive protein, lipid profile, serum 
glucose, homocysteine, and genetic markers) 
 ■ Information about the disease outcome: for each study it was 
documented how a first episode of acute myocardial infarction 
or stroke was defined. We also documented the number of 
fatal and non-fatal episodes when this was reported.
We planned to extract data on relationship of risk factors with 
disease outcomes using two approaches depending on the two 
study designs included in this review:
 ■ cohort studies: The number of non-fatal and fatal cases of 
AMI or stroke for participants with and without the risk factor. 
 ■ case-control studies: The number of cases or controls 
exposed and not exposed to a certain risk factor. 
We planned to use this information to calculate a relative risk or 
odds ratio with a 95% confidence interval for individual studies; 
and where appropriate conduct meta-analysis. Where only the 
measure of association for a risk factor was reported this was 
extracted together with the level of precision (95% confidence 
interval, standard error or p-value). Where the measure of 
association was adjusted for potential confounding variables this 
was noted and the variables recorded. 
Quality Assessment
The quality of included cohort- and case-control studies was rated 
using adapted versions of the critical appraisal tools developed 
in the Critical Appraisal Skills Programme (CASP). (http://www. 
sph.nhs.uk/what-we-do/public-health-workforce/resources/critical-
appraisals-skills-programmeme.) Judgements of the methodolo-
gical quality focussed on internal validity and the relevant study 
design components were rated as adequate, inadequate or unclear 
according to pre-specified criteria for the two types of designs 
separately. (Appendix 2) 
Data synthesis and analyses
We described measures of association (odds ratios) with confi-
dence intervals of risk factors for AMI and stroke separately and 
summarised these in a table. Only one study assessed AMI as the 
outcome and the studies investigating stroke all assessed different 
risk factors. We could therefore not pool results or do sub group 
analyses. 
Results
We identified 862 potentially relevant articles through searching 
PubMed and EMBASE. A total of 12 articles were included in our 
review. Figure 1 presents a flowchart showing the process we 
followed in compiling the final list of articles for inclusion. The 
majority of articles were excluded because they reported on non-
African studies. Seven were excluded because the full text was 
available in French or Spanish only and eligibility could not be 
determined from the abstract. We identified no cohort studies that 
were eligible for inclusion.
The 12 articles considered in this review reported on five separate 
studies: INTERHEART(8,11-15) INTERSTROKE,(16) the WHO Colla-
borative Study of Cardiovascular Disease and Steroid Hormone 
Contraception(17-19) and two unnamed studies.(20,21) Only INTER-
HEART assessed risk factors for first episode of AMI. Data were 
separately reported for Africa collectively or for specific African 
ethnic groups in eight articles from INTERHEART. Two of these 
papers were excluded,(22,23) since the African results they reported 
were subsequently documented more fully in INTERHEART 
Africa;(8) this more recent report is included. The WHO Colla-
borative Study included cases with first time diagnosis of both AMI 
and stroke, but the number of AMI cases from Africa (four cases 
and eight controls) was too small and therefore only stroke could 
be assessed. INTERSTROKE and the two remaining studies included 
first episodes of stroke only. 




















rIsk fActors for fIrst EpIsodE of AMI              
The main findings for Africa or African ethnic groups from the 
INTERHEART study are summarised in this section and in Table I. 
INTERHEART aimed to determine the strength of association 
between various risk factors and first episode of AMI in an overall 
global population and within populations defined by ethnic group 
or geographic region.(23)
socIo-dEMogrApHIc fActors                                  
The mean age of controls and cases from Africa were 52.2 
(SD±11.5) years and 54.3 (SD±11.3) years, (p = 0.0017) respect-
ively; African cases were significantly younger than cases in 
INTERHEART overall (p <0.0001).(8) Among the black African 
population, a higher socioeconomic status as measured by the 
degree of formal education and higher income was associated 
with an increased risk of AMI. The odds ratio (OR) and 95% 
confidence interval (CI) for participants with tertiary education 
compared to those with less than eight years of schooling, was 1.86; 
95% CI: 1.06 to 3.25.(8) By contrast the study found no associa- 
tion for coloured Africans (OR 0.71; 95%CI 0.30 to 1.68) and a 
decreased risk among Africans of European descent or other 
Africans (OR 0.30; 95%CI 0.15 to 0.58).(8) In this study coloured 
Africans included a group of mixed race ancestry descending 
from the first South African nations, the Koi and San people, as well 
as European, African and Malaysian people that were mainly from 
South Africa.(8)
fIgurE 1:  flow diagram for selection of articles for inclusion in the review
862 Potentially relevant articles obtained from  
PubMed and EMBASE
12 Articles reporting on 5 separate studies included 
in this review
158 Articles reviewed in full text 
16 Articles met our inclusion criteria
4 Of these articles overlapped between databases
2 Duplicated results from the same study
704 Articles excluded during initial screening  
based on title/abstract 
265 Studies were not done in Africa
166 Outcome not first episode of AMI/stroke
107 Not case-control/ cohort study
157 A combination of the above reasons
8 Full text in a foreign language and eligibility not clear 
from abstract or title.  
(One duplicated between databases) 
1 Reported first episode of stroke in patients with atrial 
fibrillation on warfarin treatment.    
142 Articles excluded after further evaluation
71 Studies were not done in Africa
35 Outcome not first episode of AMI/stroke
21 Not a case-control/cohort study     
15 Combination of the above reasons
383 References screened from included articles
1 Article included from reference screen
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Risk fActoR PRofiLE iN AfRicA
tAblE 1: Risk factors for first episode of AMi: the iNtERHEARt study
Author (publication year)
Mente M, et al. (2010)(11)
McQueen MJ, et al. (2008)(12)
Iqbal R, et al. (2008)(13)
Steyn K, et al. (2005)(8) 







This report is limited to 
subjects who had blood 
samples available
Africa: 1367 (578:789)
This report was limited 
to subjects who did not 









Metabolic syndrome  
(WHO definition)‡






Total cholesterol /HDL cholesterol§
ApoB/ApoA1§
Dietary risk score (Q4 vs Q1)#
Western dietary pattern (Q4 vs Q1)#
Prudent dietary pattern (Q4 vs Q1)#
Hypertension (self -reported)
Diabetes (self-reported)
Current smoker (smoked in previous 
12 months)
Current/Former smoker (quit >  
a year ago)
Exercise (≥ 4 hours/week)
Alcohol (consumption ≥ 3times/
week)
Fruits and vegetables (daily)
Depression 
Stress, permanent 
Abdominal obesity  
(WHR: Tertiles 2,3 vs 1) 
Elevated ApoB/ApoA-1  
(Tertiles 2,3 vs 1)
Level of education  
(tertiary vs ≤8y schooling)
Income (Highest income versus low 
income)
combinations of risk factors:
Current/former smoking, Diabetes, HPT
Above and ApoB/ApoA-1 ratio
Above and WHR
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lIfEstylE fActors                                                      
AMI risk in current or former smokers was higher than in non-
smokers in the overall African population (OR 2.17; 95%CI 1.70 
to 2.77) while regular alcohol users had lower risk (OR 0.66; 95% 
CI 0.50 to 0.87) than non-users.(8) No statistically significant 
association was demonstrated for other lifestyle factors, including 
physical activity and daily fruit and vegetable intake in the African 
population. The risk associated with different dietary patterns was 
assessed using the information gathered through a 19-item quali-
tative food group frequency questionnaire to generate a dietary 
risk score (DRS).(13) Food items that were considered to be pre-
dictive of CVD (meat, salty snacks, and fried foods) or protective 
(fruits and vegetables) were used to generate the DRS. Intake of 
food items was grouped into quartiles (Q1 - Q4) and reference 
values were determined for intake comparisons. Although there 
was a positive relationship between the DRS and risk of AMI in 
the INTERHEART global population (Q4 vs Q1: OR 1.92; 95%CI 
1.74 to 2.11) this association was weaker and not statistically 
significant in Africa (Q4 vs Q1: OR 1.22; 95%CI 0.66 to 2.23). 
Similarly, a prudent dietary pattern (defined as a high intake of fruit 
and vegetables) was associated with a reduced risk of AMI in the 
global population (Q4 vs Q1: OR 0.67; 95%CI 0.59 to 0.76) but 
in Africa this association was not statistically significant (Q4 vs Q1: 
OR 0.73; 95%CI 0.37 to 1.46).(13) 
clInIcAl HIstory And ExAMInAtIon                    
In Africa, self-reported hypertension (OR 3.44; 95%CI 2.64 to 
4.48) and abdominal obesity (OR 2.99; 95%CI 2.20 to 4.07) 
were both associated with a higher AMI risk.(8) These associations 
were stronger than in INTERHEART as a whole (p-values for test 
of heterogeneity of effects 0.0023 and <0.0001, respectively). The 
risks associated with metabolic syndrome defined by the World 
Health Organisation (WHO) and the International Diabetes 
Federation (IDF) were similar for all geographic regions and all 
tAblE 1: Risk factors for first episode of AMi: the iNtERHEARt study continued
* In total 12 461 cases and 14 637 controls were recruited from 262 centres in 52 countries including 578 cases and 789 controls from sub Saharan Africa.(23) African countries included Benin, 
Botswana, Cameroon, Kenya, Mozambique, Nigeria, Seychelles, South Africa and Zimbabwe. More than 80% of participants were recruited from South Africa.(8,23) 
‡ The World Health Organisation (WHO) and International Diabetes Federation (IDF) defines metabolic syndrome as: self-reported diabetes mellitus or HbA1c ≥ 6.5%, self-reported hypertension 
or use of prescribed antihypertensive medication, abdominal obesity defined by waist-to-hip ratio (WHR) ≥0.9 for males or WHR ≥0.85 for females (WHO definition) or a waist circumference 
(WC) ≥94cm for males or WC ≥80cm for females (IDF definition) and an abnormal lipid profile defined by HDL-cholesterol <0.9mmol/L for males or HDL-cholesterol <1.03 mmol/L for females 
(WHO definition) OR HDL-cholesterol <1.03mmol/L for males or HDL-cholesterol <1.29mmol/L for females (IDF definition) or the use of fibrate/ niacin. With the WHO definition MS is defined 
as diabetes mellitus plus 2 or 3 of the other factors and with the IDF definition MS is defined as abdominal obesity plus 2 or 3 of the other factors.(11)
§ The odds ratio associated with one standard deviation (SD) change (increase) in each of the lipid measures.(12)  #Food items that were considered predictive of CVD (meat, salty snacks, and 
fried foods) or protective (fruits and vegetables) were used to generate a dietary risk score (DRS).  By using a point system each participant was assigned a total score.  Dietary patterns were 
classified as “western”, referring to high loadings of fried food, salty snacks and meat, and “prudent” referring to high loadings of fruit and vegetables.(13)
Author (publication year)
Yusuf S, et al. (2005)(14) 
Rosengren A, et al. (2004)(15) 
sample size in Africa*
(cases: controls)





BMI (1 SD increase)
Waist circumference (1 SD increase)
WHR (1 SD increase )
Overweight (BMI>25)
Obese (BMI>30 )
Raised WHR (>0.83 women;  
>0.9 men)
High general stress (Several periods 
of or permanent stress at work,  
home or both.)
Depressive mood (Feeling sad, blue or 
depressed for ≥2 consecutive weeks 
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ethnic groups. For the African population, the risk associated 
with metabolic syndrome was higher when using the WHO 
definition (OR 3.29; 99% CI 2.21 to 4.89) compared to the IDF 
definition (OR 2.48; 99% CI 1.77 to 3.47) and with both defini- 
tions the risk was higher in Africa compared to the global popula-
tion (OR 2.69; 99% CI 2.45 to 2.95 and OR 2.20; 99% CI 2.03 to 
2.38, respectively).(11) Three physical measurements were evalu-
ated as potential risk factors for AMI: body mass index (BMI), waist-
to-hip ratio (WHR) and waist circumference (WC).(14) In the global 
population one standard deviation (SD) increase in WHR showed 
the strongest association with AMI (OR 1.37; 95%CI 1.34 to 1.41) 
and a similar increase in BMI the weakest association (OR 1.10; 
95%CI 1.07 to 1.13). Similarly in the black and the coloured African 
groups one SD increase in WC (OR 1.57; 95%CI 1.31 to 1.88) 
and one SD increase in WHR (OR 2.25; 95%CI 1.79 to 2.84) 
showed the strongest associations with AMI, respectively.(14) Thus 
markers of abdominal obesity (WHR or WC) were found to be 
better predictors of AMI than BMI in the INTERHEART study.(14) 
General stress and depressive mood were assessed as psychosocial 
risk factors for AMI.(15) The association between high stress levels 
and AMI was similar in Africa (OR 1.51; 99%CI 1.07 to 2.12) and 
the overall population (OR 1.55; 99%CI 1.42 to 1.68). The associ-
ation between depressive mood and AMI was slightly stronger in 
Africa (OR 1.69; 99%CI 1.20 to 2.39) compared to the overall 
population (OR 1.55; 99% CI 1.42 to 1.69).(15) 
bIologIcAl MArkErs                                                  
For the assessment of risk associated with lipids, lipoproteins and 
apolipoproteins non-fasting blood samples were available from 
405 black African participants and 510 coloured African partici-
pants.(12) The Apolipoprotein B100/Apolipoprotein A1 ratio (ApoB/
Apo A1) was the most powerful lipid marker for increased risk of 
AMI. In the global population one SD increase in the ApoB/Apo 
A1 ratio was a stronger predictor (OR 1.59; 95% CI 1.52 to 1.64) 
than a similar increase in the Total/HDL cholesterol ratio (OR 1.17; 
95% CI 1.13 to 1.20).(12) Similarly, one SD increase in the ApoB/
Apo A1 ratio was a stronger predictor among the coloured African 
group, but not among the black African group.(12)
rIsk fActors for fIrst EpIsodE of A strokE
The main findings for stroke in Africa or African ethnic groups 
from studies included in this review are summarised in this section 
and in Table 2.
socIo-dEMogrApHIc fActors                                  
The objective of the INTERSTROKE study was to determine the 
strength of association between various risk factors and the first 
episode of stroke and primary stroke subtypes in high, middle and 
low income countries.(24) In this study the mean age of cases from 
Africa was 57.7 (SD ±15.3) years compared to a mean age of 61.1 
(SD ±12.7) years in the global population.(24) Twenty-two percent 
(71 of 323) of strokes in Africa were fatal compared to only 9% 
(260 of 3 000) in the global population.(24) Stroke was defined by 
brain CT or MRI in all cases from Africa in the INTERSTROKE 
study,(24) in contrast to the WHO collaborative study where 83% of 
stroke cases from Africa were not classified into subtypes due to 
the absence of definitive diagnostic evaluation.(25)
The WHO collaborative study aimed to determine the associ- 
ation between current oral contraceptive use and cardiovascular 
diseases and cases from Africa included women aged 15 to 49 
years.(26) Chang et al. used the data collected in this study to assess 
the association between socio-economic status (SES) and AMI or 
stroke. SES was defined by the level of educational attainment, 
stratified into high (beyond secondary schooling), secondary and 
low (primary or no schooling).(17) There was a statistically signifi-
cant inverse relationship between educational attainment and all 
stroke types combined in all countries, except in Africa. However, 
after adjustment for other risk factors SES was not a statistically 
significant factor overall or in Africa.(17) 




















tAblE 2: Risk factors for first episode of stroke
* In the first phase of the INTERSTROKE study 3000 case-control pairs were recruited from 84 centres in 22 countries, including 5 African countries (Mozambique, Nigeria, South Africa, Sudan, 
and Uganda).  ‡The presence of the Apolipoprotein E (Apo E) and Angiotensin-Converting Enzyme (ACE) insertion-deletion (Ins/Del) genotypes were assessed individually and in combination as 
risk factors for ischaemic stroke.  §In the WHO collaborative study a total of 2162 stroke cases and 5984 controls were recruited from 21 centres in 17 countries, including 3 African countries 
(Kenya, Zambia, Zimbabwe).  **Level of educational attainment was stratified into high (beyond secondary schooling), secondary and low (primary or no schooling) with high education used as 
reference group.  #Current use of COC: Use of an OC at any time in the 3 months before the stroke for cases or before hospital admission for controls.  Non-user was defined as past-users or 
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clInIcAl HIstory And ExAMInAtIon                    
INTERSTROKE confirmed that hypertension was a strong risk 
factor for stroke overall (OR 3.89; 99% CI 3.33 to 4.54) and this 
association was higher in Africa (OR 4.96; 99%CI 3.11 to 7.91).(24) 
Globally, the association of hypertension was stronger for parti-
cipants younger than 45 years (OR 8.53; 99%CI: 5.39 to 13.49), 
which is important considering that Africa had the highest pro-
portion of cases ≤45 years (77 of 323; 24%).(24) 
Two earlier reports from the WHO collaborative study investi-
gated current use of combined oral contraceptives (COC) as a risk 
factor for stroke.(18,19) Current use of COC increased the risk of 
haemorrhagic stroke in all countries, except in Africa and Europe, 
where no statistically significant association was found (adjusted 
OR for Africa: 1.31; 95%CI: 0.29 to 5.96).(19) Similarly, the ad- 
justed OR for ischaemic stroke was significantly raised for current 
users of COC in all countries except in Africa where this associ-
ation was not significant (OR 1.21; 95%CI: 0.24 to 6.05).(18)
bIologIcAl MArkErs                                                   
Okubadejo et al. investigated the risk associated with hyper-
homocysteinemia in 69 cases of ischaemic stroke compared to 86 
controls in Nigeria and found no significant difference between 
the mean homocysteine level in acute stroke cases and controls 
(P = 0.88).(20) Furthermore, hyperhomocysteinemia was not 
found to be risk factor for ischaemic stroke in this population 
(OR 0.77; 95%CI: 0.27 to 2.12).(20) 
The only study that investigated genetic risk factors specifically for 
first episode of stroke was Saidi et al.(21) These researchers studied 
the association of the apolipoprotein E and the angiotensin-
converting enzyme (ACE) insertion-deletion (Ins/Del) genotypes 
individually and in combination as risk factors for ischaemic 
stroke.(21) Their study of 551Tunisian Arabs found a higher fre-
quency of a combination of the Apo E4-containing and ACE Del/
Del genotype in cases than controls (OR 2.67, 95%CI 1.66 to 
4.30; p-value <0.001) and this association was more pronounced 
among cases over the age of 50 years (OR 3.04; 95%CI 1.32 to 
6.70).(21) The Apo E4-containing genotypes were significantly more 
prevalent among cases than controls (p <0.001) and the homo-
zygous E4/E4 genotype was associated with the highest risk (OR 
4.38; 95%CI 2.05 to 8.80).(21) 
rIsk of bIAs In IncludEd studIEs                         
In general, the quality of the five case-control studies included in 
this review is good. (Appendix 3). All the studies addressed a 
research question that was clearly defined in terms of the popu-
lation, the risk factors and the outcome under investigation. Cases 
were defined precisely in all studies. INTERHEART and INTER-
STROKE did not clearly indicate their target geographic populations 
in Africa. The controls were selected in an acceptable way in all 
studies, except in the studies of Okubadejo et al.(20) and Saidi et 
al.(21) where it was unclear whether the controls were selected from 
the same study base as the cases. The exposures were clearly 
defined and measured in an objective manner and in a similar way 
among cases and controls in all studies. All the studies reported 
baseline characteristics for cases compared to controls. Most 
authors applied restrictions in the design through matching for 
age, gender and region, and adjusted for potential confounders 
in their analyses. However, Saidi et al. did not adjust their analyses 
for potential confounding resulting from significant differences in 
blood pressure and biological markers of cases compared to 
controls.(21) Okubadejo et al. used matching in their study design 
but it was not clear if they had adjusted for significant differences 
in hypertension and diabetes between cases and controls.(20)
dIscussIon                                                                         
We have conducted a thorough and systematic search for case-
control and cohort studies investigating risk factors for first episode 
of AMI and stroke in Africa. Our results indicate that there is no 
data available from cohort studies in the African population. To 
date INTERHEART is the only study to investigate risk factors 
associated with first episode of AMI in Africa. Despite being the 
largest study of its kind(8) to have included sub-Saharan African 




















countries, participants from Africa still represented only 5% of the 
total study population. More than 80% of the African sample was 
drawn from South Africa, and thus low-income countries in Africa 
are poorly represented in this study.(23) Similarly, in INTERSTROKE 
and the WHO Collaborative Study less than 11% of the total 
sample was from Africa. Data from these global studies do not 
adequately reflect the diversity found in Africa. Furthermore, the 
small numbers of participants from Africa preclude firm conclusions 
regarding disease-exposure associations as studies carry the risk of 
spurious findings due to chance. 
Current evidence suggests that the direction of association for 
established risk factors for AMI(8,11-15) and stroke(24) are similar across 
countries but that the strength of association of particular risk 
factors varies between countries and within African ethnic groups. 
Hypertension and diabetes were found to be stronger risk factors 
for AMI in Africa than in the global INTERHEART population, with 
the risk being almost two-fold higher for the black African group.(8) 
Similarly, abdominal obesity and an elevated ApoB /ApoA-1 ratio 
show a stronger association in Africa and are the most pronounced 
among the coloured and European African groups.(8,12,14) Hyper-
tension was the predominant risk factor for all stroke subtypes and 
the association was the strongest in Africa.(24) 
Higher socio-economic status defined by increasing levels of 
education and higher income was associated with higher risk of 
AMI in the black African group, in contrast to the other African 
groups.(8) Women with the highest level of education were at the 
highest risk of all types of stroke in Africa in contrast to the other 
countries.(17)  
This variation in the direction of association may represent dif-
ferences in stages of epidemiologic transition, differences in lifestyle 
and perhaps underlying genetic differences within African popu-
lations and between continents. Only one study assessing a genetic 
risk factor met our inclusion criteria(21) indicating that there is a 
lack of research investigating possible genetic risk factors for first 
episode of AMI and stroke. There have been no major epidemi-
ological studies investigating the potential influence of infectious 
diseases on the risk of first episodes of AMI and stroke, which is 
concerning given the high burden of infectious diseases in Africa.
strEngtHs And lIMItAtIons of our rEvIEW   
We are not aware of previous systematic reviews addressing our 
research question and believe that our review gives the most 
comprehensive result on the topic to date. We used systematic 
methods to reduce bias in the identification of studies, extraction of 
relevant data, appraisal of study quality and synthesis of information. 
However, there are limitations to our work; although a compre-
hensive search strategy without language restrictions was used in 
our review only two databases were searched. Seven articles were 
excluded because the full text was only available in a language other 
than English and eligibility could not be determined from the 
abstract. A future update of this review should include translations 
of reports published in languages other than English. We could not 
conduct meta-analysis as planned since there was only one study 
assessing risk factors for AMI and the studies investigating stroke all 
assessed different risk factors. 
futurE rEsEArcH                                                             
The importance of various risk factors can be determined either 
through prospective cohort studies in which exposures are 
measured in a large group of participants who are then followed up 
over time until an adequate number develop the outcome of 
interest or through case-control studies in which the distribution of 
exposures between cases and controls are compared retro-
spectively. The need for large prospective studies has been 
recognised internationally.(27,28) The Prospective Urban Rural Epi-
demiology (PURE) study was initiated in 2002 and plans to recruit 
157 000 participants from 17 countries worldwide, in order to 
investigate societal, lifestyle and cardiovascular risk factors for 
chronic non-communicable diseases (CNCDs).(28) Target recruit-
ment goals from Africa (including South Africa and Zimbabwe) are 
3 000 participants, i.e. two percent of the total sample.(28) The 
Global Epidemiology Initiative established at the Harvard School 
of Public Health aims to address the need for cohort studies in 
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Africa by establishing a Partnership for Cohort research and Training 
(PaCT), an ambitious project which will investigate CNCDs among 
500 000 people from four African countries over the next decade. 
Cohort studies have certain strengths compared to case-control 
studies: 
 ■ Temporal and causal relationships between exposures and out-
comes can be investigated.
 ■ Multiple outcomes of a particular exposure can be assessed 
which is important for chronic diseases that share common risk 
factors.
 ■ The incidence of disease and changes in risk factors over time 
can be monitored. 
 ■ A cohort can provide a study population for embedded 
randomised controlled trials of interventions. 
 ■ The potential for recall bias and selection bias are limitations of 
case-control studies and these can be reduced in a prospective 
cohort study. This is particularly important when measuring 
subjective factors, such as lifestyle (including diet and physical 
activity) and psychosocial factors (including stress and depres-
sive mood). Since these risk factors are also dynamic, they will 
be better assessed during prospective follow-up. The main 
drawbacks of cohort studies are that they cost more and take 
longer to complete. Successful follow-up of participants also 
presents a substantial challenge. In developing countries, inno-
vative measures such as the use of cell phones are being 
considered to ensure high levels of participant retention in 
long-term cohort studies.(29) 
conclusIons And rEcoMMEndAtIons               
Our review highlights the complete lack of data from cohort studies 
investigating risk factors for first episode of AMI or stroke in Africa. 
A few high quality case-control studies exist but these do not 
adequately represent the cultural and genetic diversity in Africa or 
the influence of infections on cardiovascular outcomes. Dynamic 
risk factors that rely on self-report such as diet, physical activity and 
stress will be better assessed through longitudinal cohort studies. 
Large cohort studies investigating established and new risk factors 
for cardiovascular diseases among African populations are urgently 
needed in order to prepare for the rising burden imposed by these 
diseases. 
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